Lexeo Therapeutics Total Current Liabilities

Lexeo Therapeutics (LXEO) currently reports a total current liabilities of $14M as of March 2026. That compares with $31M in the prior-year period — down 54.0% year over year. Use the charts on this page to explore Lexeo Therapeutics's total current liabilities history and peer comparisons.

Lexeo Therapeutics's total current liabilities decreased from $31M to $14M — a 54.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexeo Therapeutics reported $14M in total current liabilities as of March 2026. That compares with $31M in the prior-year period — down 54.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexeo Therapeutics, and consider following LXEO for alerts when major investors trade the stock.